Cancer was linked to toxic substances since the 1700s, but understanding of causes shifted from irritation to chemicals, viruses, and radiation over time. In the 1970s, cancer research led to stronger government rules to control harmful substances and protect people. Today, cancer risk guides many safety laws and health policies.
-
For its next phase of growth, India needs a new reform agenda #
, 5 highlightsFew in India believe the country can achieve double-digit growth. The East Asian countries benefited from huge inflows of foreign investment and the exports of a job-rich low-skill manufacturing sector. That helped them deepen their links to global value chains at a time of rampant globalisation. India’s rise began later and followed a different path.
India’s path has, therefore, been singular: its exports have been led not by manufacturing but by a productive yet job-poor it and services sector, and its companies are led by a handful of sprawling conglomerates along with a long tail of small informal businesses.
But there is no avoiding the economy’s shortcomings. The labour market is weak, with a majority of Indians underemployed or out of the labour force altogether. That limits consumption, and exports do not make up the shortfall.
Over three decades of reform, growth has averaged 6.4% a year. Though it has averaged 5.6% during the decade of Mr Modi’s rule, that has been in line with a broader slowdown in global growth.
Mr Modi’s ambition of viksit Bharat, or developed-country status, by 2047 (in the form of a gdp per head of $14,000) needs a broader perspective. It is one in which all the 28 states are capable of competing against each other economically, giving business leaders opportunities beyond the prosperous south.
-
The Case for Bridge Editors #
, 2 highlightsBridge recombinase is. ... a genome-editing tool made from two parts: a protein (called the recombinase) that cuts and rejoins strands of DNA, and a RNA molecule (called the ‘Bridge’) that guides the recombinase to a specific site in a cell’s genome.
All CRISPR gene-editing tools share a flaw, though: they rely on cell repair pathways to make their edits. If a researcher wants to permanently “shut down” a gene, for example, they might use CRISPR-Cas9. The Cas9 protein goes into the genome and makes a cut at the position indicated by its guide RNA. But the Cas9 protein itself doesn't then fix the DNA it has broken. The cell has to fix that damage a different way.
Cells have two main ways to fix DNA breaks. Non-homologous end joining quickly slaps the two broken strands together, often adding or deleting random bits of DNA in the process. It is messy, but fast. The second option, homology-directed repair, uses a matching DNA template to fix the break. Basically, scientists can introduce a DNA "donor template" into cells alongside CRISPR-Cas9. The cell sees this template as the correct version of the sequence and copies from it to fix the break. But homology-directed repair only works reliably during specific phases of the cell cycle and happens less frequently than non-homologous end joining.
Because CRISPR relies on these cellular repair pathways, its edits are inherently unpredictable. [3] Cellular repair systems are non-deterministic (sometimes the cell uses one option, and sometimes it uses the other), and different cells therefore produce different results. Bridge recombinases bypass these cellular pathways, which could make their edits more predictable. [4]
-
The Origin of Life on Earth #
, 1 highlightunder the right conditions some building blocks of proteins, the amino acids, form easily from simpler chemicals, ... But going from there to proteins and enzymes is a different matter.